Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
December 3, 2021
Probable Interaction Between Warfarin and Divalproex Sodium
Sarah L Anderson, Joel C Marrs
Therapeutic Advances in Drug Safety
|
October 20, 2015
Suvorexant in insomnia: efficacy, safety and place in therapy
Danielle N Rhyne, Sarah L Anderson
The Annals of Pharmacotherapy
|
March 22, 2012
Dapagliflozin for the treatment of type 2 diabetes
Sarah L Anderson, Joel C Marrs
American Family Physician
|
December 25, 2013
Case report: Risk of uterine perforation from IUDs is greatest during postpartum period
Sarah L Anderson, Laura M Borgelt
Drugs in Context
|
December 9, 2020
Ertugliflozin in the treatment of type 2 diabetes mellitus
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
August 18, 2018
Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
Sarah L Anderson, Joel C Marrs
Drugs in Context
|
December 6, 2024
Inclisiran for the treatment of hypercholesterolaemia
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
September 14, 2020
Bempedoic acid for the treatment of dyslipidemia
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
July 1, 2022
Diabetes: how to manage cardiovascular risk in secondary prevention patients
Sarah L Anderson, Joel C Marrs
Advances in Therapy
|
March 1, 2018
A Review of the Role of the Pharmacist in Heart Failure Transition of Care
Sarah L Anderson, Joel C Marrs
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
December 3, 2021
Probable Interaction Between Warfarin and Divalproex Sodium
Sarah L Anderson, Joel C Marrs
Therapeutic Advances in Drug Safety
|
October 20, 2015
Suvorexant in insomnia: efficacy, safety and place in therapy
Danielle N Rhyne, Sarah L Anderson
The Annals of Pharmacotherapy
|
March 22, 2012
Dapagliflozin for the treatment of type 2 diabetes
Sarah L Anderson, Joel C Marrs
American Family Physician
|
December 25, 2013
Case report: Risk of uterine perforation from IUDs is greatest during postpartum period
Sarah L Anderson, Laura M Borgelt
Drugs in Context
|
December 9, 2020
Ertugliflozin in the treatment of type 2 diabetes mellitus
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
August 18, 2018
Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
Sarah L Anderson, Joel C Marrs
Drugs in Context
|
December 6, 2024
Inclisiran for the treatment of hypercholesterolaemia
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
September 14, 2020
Bempedoic acid for the treatment of dyslipidemia
Joel C Marrs, Sarah L Anderson
Drugs in Context
|
July 1, 2022
Diabetes: how to manage cardiovascular risk in secondary prevention patients
Sarah L Anderson, Joel C Marrs
Advances in Therapy
|
March 1, 2018
A Review of the Role of the Pharmacist in Heart Failure Transition of Care
Sarah L Anderson, Joel C Marrs
Page
of 6